News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,800 Results
Type
Article (39440)
Company Profile (249)
Press Release (654111)
Section
Business (204056)
Career Advice (2006)
Deals (35408)
Drug Delivery (93)
Drug Development (80974)
Employer Resources (169)
FDA (16141)
Job Trends (14833)
News (344938)
Policy (32482)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2538)
Accelerated approval (2)
Adcomms (20)
Allergies (77)
Alliances (49334)
ALS (75)
Alzheimer's disease (1322)
Antibody-drug conjugate (ADC) (98)
Approvals (16126)
Artificial intelligence (209)
Autoimmune disease (10)
Automation (14)
Bankruptcy (357)
Best Places to Work (11638)
BIOSECURE Act (18)
Biosimilars (92)
Biotechnology (177)
Bladder cancer (50)
Brain cancer (23)
Breast cancer (231)
Cancer (1789)
Cardiovascular disease (133)
Career advice (1670)
Career pathing (28)
CAR-T (130)
Cell therapy (373)
Cervical cancer (13)
Clinical research (65385)
Collaboration (698)
Compensation (393)
Complete response letters (18)
COVID-19 (2571)
CRISPR (31)
C-suite (178)
Cystic fibrosis (97)
Data (1711)
Decentralized trials (2)
Denatured (14)
Depression (35)
Diabetes (223)
Diagnostics (6300)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (104)
Drug pricing (94)
Drug shortages (24)
Duchenne muscular dystrophy (64)
Earnings (85713)
Editorial (27)
Employer branding (21)
Employer resources (145)
Events (111192)
Executive appointments (588)
FDA (17108)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (630)
Gene editing (85)
Generative AI (18)
Gene therapy (255)
GLP-1 (659)
Government (4366)
Grass and pollen (4)
Guidances (46)
Healthcare (18786)
Huntington's disease (22)
IgA nephropathy (19)
Immunology and inflammation (91)
Indications (23)
Infectious disease (2690)
Inflammatory bowel disease (125)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (70)
Interviews (311)
IPO (16470)
IRA (40)
Job creations (3627)
Job search strategy (1421)
Kidney cancer (9)
Labor market (26)
Layoffs (441)
Leadership (14)
Legal (7891)
Liver cancer (68)
Lung cancer (260)
Lymphoma (119)
Machine learning (2)
Management (57)
Manufacturing (245)
MASH (57)
Medical device (13284)
Medtech (13289)
Mergers & acquisitions (19343)
Metabolic disorders (580)
Multiple sclerosis (59)
NASH (16)
Neurodegenerative disease (69)
Neuropsychiatric disorders (23)
Neuroscience (1748)
NextGen: Class of 2025 (6511)
Non-profit (4476)
Northern California (2213)
Now hiring (35)
Obesity (319)
Opinion (196)
Ovarian cancer (61)
Pain (69)
Pancreatic cancer (69)
Parkinson's disease (117)
Partnered (17)
Patents (180)
Patient recruitment (80)
Peanut (45)
People (56915)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20361)
Phase II (28802)
Phase III (21447)
Pipeline (806)
Podcasts (40)
Policy (101)
Postmarket research (2563)
Preclinical (8590)
Press Release (64)
Prostate cancer (84)
Psychedelics (30)
Radiopharmaceuticals (242)
Rare diseases (335)
Real estate (5897)
Recruiting (64)
Regulatory (21995)
Reports (43)
Research institute (2314)
Resumes & cover letters (349)
Rett syndrome (2)
RNA editing (1)
RSV (36)
Schizophrenia (58)
Series A (114)
Series B (68)
Service/supplier (11)
Sickle cell disease (49)
Southern California (1888)
Special edition (13)
Sponsored (28)
Startups (3569)
State (2)
Stomach cancer (11)
Supply chain (56)
The Weekly (25)
United States (19415)
Vaccines (625)
Venture capitalists (34)
Webinars (12)
Weight loss (216)
Women's health (30)
Worklife (13)
Date
Today (167)
Last 7 days (753)
Last 30 days (2935)
Last 365 days (34354)
2025 (5688)
2024 (35219)
2023 (40076)
2022 (51175)
2021 (55713)
2020 (54087)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (717)
Alabama (48)
Alaska (7)
Arizona (212)
Arkansas (12)
Asia (37557)
Australia (6142)
California (5035)
Canada (1761)
China (414)
Colorado (230)
Connecticut (240)
Delaware (111)
Europe (80536)
Florida (742)
Georgia (172)
Idaho (57)
Illinois (465)
India (20)
Indiana (274)
Iowa (7)
Japan (126)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (59)
Maryland (771)
Massachusetts (3831)
Michigan (201)
Minnesota (347)
Mississippi (2)
Missouri (71)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (61)
New Jersey (1428)
New Mexico (27)
New York (1440)
North Carolina (868)
North Dakota (7)
Northern California (2213)
Ohio (177)
Oklahoma (13)
Oregon (32)
Pennsylvania (1144)
Puerto Rico (6)
Rhode Island (23)
South America (1093)
South Carolina (13)
South Dakota (1)
Southern California (1888)
Tennessee (83)
Texas (738)
Utah (155)
Virginia (116)
Washington D.C. (55)
Washington State (478)
West Virginia (3)
Wisconsin (44)
693,800 Results for "medicago inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Medicago announces the appointment of Toshifumi Tada as President and CEO
Medicago, a biopharmaceutical company headquartered in Quebec City, Canada, announced the appointment of Toshifumi Tada as President and chief executive officer, effective on May 1, 2022.
April 28, 2022
·
2 min read
Press Releases
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
February 27, 2025
·
4 min read
Press Releases
Moss Genomics Inc. Announces Leadership Changes
February 26, 2025
·
5 min read
Press Releases
Albertsons Companies, Inc. Announces CEO Succession Plan
March 3, 2025
·
8 min read
Drug Development
Medicago submits Phase 3 data to Health Canada for its plant-based COVID-19 vaccine candidate
Medicago, a biopharmaceutical company headquartered in Quebec City, is pleased to announce submission of the positive Phase 3 data for regulatory review by Health Canada as part of the New Drug Submission for COVID (NDS-CV) rolling review for Medicago’s COVID-19 vaccine candidate combined with GSK’s pandemic adjuvant.
December 16, 2021
·
3 min read
Policy
Health Canada authorizes Medicago COVID-19 vaccine for adults 18 to 64 years of age
Health Canada authorized Medicago’s Covifenz COVID-19 vaccine for the prevention of COVID-19 in adults 18 to 64 years of age.
February 24, 2022
·
2 min read
Press Releases
AEON Biopharma, Inc. to Participate in the Leerink Global Healthcare Conference
March 4, 2025
·
1 min read
Press Releases
Tivic Health Systems, Inc. Announces Reverse Stock Split
March 5, 2025
·
6 min read
Drug Development
Medicago announces publication of Phase 3 COVID-19 vaccine study results in New England Journal of Medicine
Medicago today announced the publication of the results from the Phase 3 study of COVIFENZ®, COVID-19 vaccine (plant-based virus-like particles [VLP], recombinant, adjuvanted), in the New England Journal of Medicine (NEJM).
May 5, 2022
·
2 min read
Press Releases
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
February 12, 2025
·
6 min read
1 of 69,380
Next
